Valuation: Vineet Laboratories Limited

Market Cap 56Cr 58.62L 51.24L 47.09L 43.9L 83.26L 84.52L 5.65Cr 2.2Cr 27Cr 2.2Cr 2.15Cr 95Cr P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 96Cr 1Cr 87.73L 80.63L 75.15L 1.43Cr 1.45Cr 9.68Cr 3.76Cr 47Cr 3.77Cr 3.69Cr 161.85Cr EV / Sales 2024
5,87,502x
EV / Sales 2025 8,90,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
1 day+0.09%
1 week-1.03%
Current month-0.47%
1 month-2.15%
3 months+14.03%
6 months-2.21%
Current year-8.51%
1 week 32.5
Extreme 32.5
34.6
1 month 32.5
Extreme 32.5
35.79
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
124
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Chief Executive Officer 56 10/11/2016
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 56 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-1.03%+1.54%-35.97% 67.88L
+1.86%+0.48%+55.50%+163.08% 1,08200Cr
+3.57%+3.29%+68.60%+61.03% 63TCr
+3.99%+3.05%+37.93%+93.37% 46TCr
+3.86%+1.64%+32.57%+24.89% 34TCr
-0.56%+0.96%+41.67%+39.35% 30TCr
-0.08%+1.30%+32.15%+44.48% 29TCr
-1.54%+2.81%-25.35%-39.61% 22TCr
+3.55%+4.41%+25.45%+66.28% 20TCr
+4.21%+2.65%+17.47%+71.11% 16TCr
Average +1.90%+4.02%+28.75%+48.80% 36.92TCr
Weighted average by Cap. +2.25%+5.53%+42.31%+83.31%

Financials

2024 2025
Net sales 1.51T 15.86 13.86 12.74 11.87 22.52 22.86 152.92 59.45 742.07 59.51 58.24 2.56T 769.53 8.08 7.07 6.49 6.05 11.48 11.65 77.95 30.3 378.26 30.34 29.69 1.3T
Net income 1.03Cr 1L 94.3T 86.66T 80.78T 2L 2L 10.4L 4L 50.49L 4L 4L 1.74Cr -20Cr -21.21L -18.54L -17.04L -15.88L -30.12L -30.58L -2.05Cr -79.51L -9.92Cr -79.6L -77.89L -34Cr
Net Debt 44Cr 46.29L 40.46L 37.19L 34.66L 65.74L 66.74L 4.46Cr 1.74Cr 22Cr 1.74Cr 1.7Cr 75Cr 40Cr 41.74L 36.49L 33.53L 31.26L 59.28L 60.18L 4.03Cr 1.56Cr 20Cr 1.57Cr 1.53Cr 67Cr
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
03/26/03 ₹33.65 +0.09% 5,510
02/26/02 ₹33.62 +1.08% 11,357
01/26/01 ₹33.26 -1.63% 9,171
30/26/30 ₹33.81 +1.41% 27,486
29/26/29 ₹33.34 -1.94% 58,192
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock